You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR ZILRETTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Zilretta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02116972 ↗ Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee Completed Flexion Therapeutics, Inc. Phase 2 2014-04-01 The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control).
NCT02357459 ↗ Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee Completed Flexion Therapeutics, Inc. Phase 3 2015-01-01 The purpose of this study was to assess the safety and efficacy of FX006 for the treatment of pain in patients with osteoarthritis of the knee.
NCT02468583 ↗ Proof of Concept Study Comparing FX006 to KenalogĀ®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee Terminated Flexion Therapeutics, Inc. Phase 2 2015-02-01 This study was a double-blind, randomized, parallel group, proof of concept study comparing FX006 to KenalogĀ®-40 (triamcinolone acetonide injectable suspension, USP) in patients with post-traumatic osteoarthritis of the knee.
NCT02637323 ↗ Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee Completed Flexion Therapeutics, Inc. Phase 2 2015-11-01 The objectives of this study were to characterize the local extent and duration of exposure of TA from FX006 and TCA IR, characterize the systemic PK of FX006 and TCA IR, and assess the safety and general tolerability of a single 5 mL IA injection of 32 mg FX006 relative to 40 mg of TCA IR in patients with OA of the knee.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Zilretta

Condition Name

Condition Name for Zilretta
Intervention Trials
Osteoarthritis, Knee 5
Osteoarthritis of the Knee 4
Knee Osteoarthritis 2
Osteoarthritis of the Shoulder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Zilretta
Intervention Trials
Osteoarthritis, Knee 12
Osteoarthritis 12
Bursitis 3
Inflammation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zilretta

Trials by Country

Trials by Country for Zilretta
Location Trials
United States 75
Australia 3
Canada 3
Denmark 1
Lithuania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Zilretta
Location Trials
Pennsylvania 8
California 8
Texas 6
North Carolina 5
Florida 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zilretta

Clinical Trial Phase

Clinical Trial Phase for Zilretta
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 10
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Zilretta
Clinical Trial Phase Trials
Completed 8
Recruiting 5
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zilretta

Sponsor Name

Sponsor Name for Zilretta
Sponsor Trials
Flexion Therapeutics, Inc. 11
Medpace, Inc. 1
The University of Texas Health Science Center, Houston 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Zilretta
Sponsor Trials
Industry 13
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.